Creating vaccines for enteroviruses and rhinoviruses
Official title: Design and testing picornavirus vaccine candidates
Funded at Vanderbilt University Medical Center · NIH-10863659 · Data updated 2026-11-12
This study is working on a fast way to create vaccines that can help protect kids from common viruses that cause colds and stomach bugs, making sure they can quickly adapt to new strains to keep everyone safe and healthy.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Vanderbilt University Medical Center NIH-funded |
| Lab location | 1 site (Nashville, United States) |
| Project start | August 20, 2024 |
| Project end | July 31, 2027 |
| Funding year | 2024 |
| Award (this year) | $5,864,929 |
| NIH project number | 1U19AI181979-01 |
| Project ID | NIH-10863659 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation or benefit from this research are children under the age of 11 who are at risk for infections caused by enteroviruses and rhinoviruses.
✕Less likely to help
Patients who are older than 11 years or those who do not have a history of infections related to these viruses may not receive direct benefits from this research.
What this research studies
This research focuses on developing a rapid vaccine platform to combat enteroviruses and rhinoviruses, which are significant causes of respiratory and gastrointestinal diseases, especially in children. The approach involves designing immunogens that target vulnerable sites on these viruses, utilizing advanced techniques in molecular biology and immunology. By adapting quickly to emerging strains, the project aims to enhance vaccine efficacy and accessibility, ultimately protecting populations from these viral threats.
Why it matters
Potential benefit: If successful, this research could lead to effective vaccines that significantly reduce the incidence of serious viral infections in children.
How similar studies have gone: Previous research has shown promise in developing vaccines for similar viral infections, indicating that this approach has the potential for success.
Where this research is happening
-
Vanderbilt University Medical Center
Nashville, United States Active
Researchers
- Principal investigator: Andino, Raul — Vanderbilt University Medical Center
- Study coordinator: Andino, Raul
Related research
Other NIH-funded projects on the same topics.
-
Improving healthcare for patients with inherited cancer syndromes using a web-based platform
This study is testing a new online tool called MeTree that helps people understand their risk for inherited cancer by combining their medical records and family health history, making it easier for patients and doctors to get the information they need for better care and support.
-
Stroke prevention with hydroxyurea for children with sickle cell anemia in Nigeria
A multinational, patient-facing study tests whether hydroxyurea can safely prevent first strokes in Nigerian children with sickle cell anemia.
-
Scaling Up Task-Shifted Epilepsy Care for Children in Africa
A study to help children with epilepsy in Africa get diagnosed and receive seizure care through trained community health workers.
-
Enhanced surveillance for new vaccine‑preventable diseases
A Vanderbilt team is tracking how well vaccines work and how diseases like flu, RSV, norovirus, and SARS‑CoV‑2 affect young children over time.
-
Generative AI to create private, fair health data for research
A researcher at Vanderbilt aims to use Generative AI to create synthetic health data that protects patient privacy while helping AI models be fairer and more accurate.
-
ConProject-003: A patient-facing initiative at Vanderbilt for advancing care
A Vanderbilt-led project (ConProject-003) is funded to drive improvements in care for people with a specific health condition through a dedicated program.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.